Sabby Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Sabby Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12	Closed	-$19K	–	361
2016 Q2	$19K	Hold	12	–	–	﹤0.01%	285
2016 Q1	$25K	Sell	12 -5	-29%	-$111	﹤0.01%	291
2015 Q4	$33K	Sell	17 -2	-11%	-$39	﹤0.01%	311
2015 Q3	$47K	Sell	19 -64	-77%	-$1.68K	﹤0.01%	373
2015 Q2	$243K	Sell	83 -59	-42%	-$1.78K	0.01%	295
2015 Q1	$413K	Buy	142 +15	+12%	+$364	0.02%	244
2014 Q4	$286	Buy	127 +58	+84%	+$1.57K	0.01%	204
2014 Q3	$207	Buy	+69	New	+$1.99K	0.01%	220

Sabby Management's IPCI Position: Q1 2019 in Review

Sabby Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 1,944,978 shares — an estimated $469K sold.

Sabby Management first reported a position in IPCI in Q2 2014 and held it in 6 quarters. The position peaked at $1.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

Sabby Management reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 1,944,978 Intellipharmaceuticals International Inc. shares in Q1 2019, an estimated $469K.
Sabby Management first reported a position in Intellipharmaceuticals International Inc. in Q2 2014 and held it in 6 quarters.
Sabby Management's Intellipharmaceuticals International Inc. position peaked at $1.2M in Q2 2014.
0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.